Florian Dr. Reiter

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (4)

Julia Mayerle

Professor and Chair

Ludwig-Maximilians-Universität München

GERMANY

View details

Katrin Böttcher

University of Tübingen

GERMANY

View details

Lorenz Balcar

Medical University of Vienna

AUSTRIA

View details

Enrico N De Toni

University Hospital

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Florian Dr. Reiter

Research Interests

Explore related searches

Contact this professor

Articles (10)

Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events

Response to: “Anticoagulation is not associated with an increased risk of variceal bleeding under systemic therapy for advanced HCC”

Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis—A real-world case series

Safety and efficacy of off-label bulevirtide monotherapy in HDV patients with decompensated Child-B cirrhosis - a real world case series

Combined hepatocellular-cholangiocarcinoma: biology, diagnosis, and management

Monitoring Dual-Cancer Treatment in a Patient With Prostate and Hepatocellular Carcinoma Using Prostate-Specific Membrane Antigen-Directed PET/CT

Response to the letter re: Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: A nationwide, population-based study

Response to the letter re: Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: A nationwide, population-based study

The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4-/- Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell Pathophysiology

Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: a nationwide, population-based study

Collaborators (4)

Julia Mayerle

Katrin Böttcher

Lorenz Balcar

Enrico N De Toni

Make your next move.